Daniel Hommes

Clinical trials

• OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome

  Principal investigator · Completed

  University of California, Los Angeles

  2017–2018
• Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

  Principal investigator · Terminated

  Jonsson Comprehensive Cancer Center

  2016–2018
• The Cirrhosis Outpatient Optimization, Readmission & Safety Study

  Principal investigator · Terminated · Early phase 1

  University of California, Los Angeles

  2015–2017
• Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment

  Principal investigator · Withdrawn · Early phase 1

  University of California, Los Angeles

  2014–2017